The first Arrowhead Pharmaceuticals trade was made in Q1 2019. Since then Joel Greenblatt bought shares four more times and sold shares on twelve occasions. The investor sold all their shares in Q3 2023 and doesn't own any shares in Arrowhead Pharmaceuticals anymore.